Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Lu Turković

6PUBLICATIONS

12CO-AUTHORS

Molecular targetsInstrumental methods (excl. immunological and bioassay methods)Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsMolecular medicine

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|Feb 12, 2026

CYP3A4-Mediated Metabolism and Drug-Drug Interaction Potential of Abemaciclib and Letrozole In Vitro.

Martin Kondža, Lu Turković, Hrvoje Rimac

|Nov 17, 2025

Surfactant-enhanced emulsification liquid-liquid microextraction combined with sweeping micellar electrokinetic chromatography-tandem mass spectrometry for therapeutic drug monitoring of alpelisib and fulvestrant in human plasma.

Zvonimir Mlinarić, Lu Turković, Biljana Nigović

|Dec 26, 2023

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors.

Matea Baković, Martina Bago, Lucija Benić

|Oct 28, 2023

Optimisation of Solid-Phase Extraction and LC-MS/MS Analysis of Six Breast Cancer Drugs in Patient Plasma Samples.

Lu Turković, Dragana Mutavdžić Pavlović, Zvonimir Mlinarić

|Nov 11, 2022

Rapid Capillary Electrophoresis Method for Simultaneous Determination of Abemaciclib, Ribociclib, and Palbociclib in Pharmaceutical Dosage Forms: A Green Approach.

Zvonimir Mlinarić, Lu Turković, Iva Begović

|May 28, 2022

Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.

Lu Turković, Luka Bočkor, Oscar Ekpenyong

Pageof 1

Frequent Collaborators

5 joint publications

Miranda Sertić

3 joint publications

Biljana Nigović

2 joint publications

Zvonimir Mlinarić

1 joint publications

Luka Bočkor

1 joint publications

Oscar Ekpenyong

1 joint publications

Dragana Mutavdžić Pavlović

1 joint publications

Martina Bago

1 joint publications

Tajana Silovski

1 joint publications

Natalija Dedić Plavetić

1 joint publications

Maja Ortner Hadžiabdić

Frequent Collaborators

5 joint publications

Miranda Sertić

3 joint publications

Biljana Nigović

2 joint publications

Zvonimir Mlinarić

1 joint publications

Luka Bočkor

Top Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on : May 20, 2015

See more related videos

Top Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Evaluating the Effectiveness of Cancer Drug Sensitization <em>In Vitro</em> and <em>In Vivo</em>

Published on : Feb 06, 2015

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Optimized LC-MS/MS Method for the High-throughput Analysis of Clinical Samples of Ivacaftor, Its Major Metabolites, and Lumacaftor in Biological Fluids of Cystic Fibrosis Patients

Published on : Oct 15, 2017

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells

Published on : May 20, 2015

See more related videos